Related by context. All words. (Click for frequent words.) 69 renal fibrosis 68 Candida infection 68 primary hyperparathyroidism 68 metastatic neuroendocrine tumors 68 imatinib resistance 68 biliary tract cancer 68 antiangiogenic therapy 68 thromboembolic disease 67 neovascularization 67 ADAMTS# 67 Lymph node 67 prostate carcinoma 67 artery stenosis 67 lung fibrosis 67 ADPKD 67 gastric adenocarcinoma 67 haematopoietic 66 pulmonary hypertension PH 66 thrombotic complications 66 diabetic kidney 66 adenomatous 66 colorectal adenocarcinoma 66 gastrointestinal stromal tumors GIST 66 CMV infections 66 AA Amyloidosis 66 allogeneic HSCT 66 colorectal liver metastases 66 colorectal adenoma 66 immunocompetent 66 alpha1 antitrypsin deficiency 66 malignant ascites 66 Aplidin 66 metastatic gastric 65 SSc 65 thoracic aortic aneurysm 65 GIST tumors 65 HER2 overexpression 65 metastatic bladder 65 antiphospholipid syndrome 65 hepatic arterial 65 erythropoietic 65 kidney urologic 65 Enzastaurin 65 choroidal vasculopathy 65 allograft rejection 65 unresectable tumors 65 nonalcoholic steatohepatitis NASH 65 cerebral vasospasm 65 Legg Calvé Perthes disease 65 gastrointestinal stromal tumors GISTs 65 LRP5 65 recurrent glioblastoma multiforme 65 hepatic toxicity 65 chlamydial 65 urothelial cancer 65 promyelocytic leukemia 65 neovascularisation 64 valvular heart disease 64 bullous 64 choroidal neovascularization 64 murine models 64 interstitial cystitis IC 64 urothelial carcinoma 64 LHRH receptor positive 64 fibrotic disease 64 papillary thyroid carcinoma 64 mesangial 64 Severe Primary IGFD 64 CYT# potent vascular disrupting 64 riociguat 64 antitumor effect 64 PCNSL 64 antibody mediated 64 pharmacologic approaches 64 haematologic 64 idiopathic pulmonary 64 acute GvHD 64 Squalamine 64 corticosteroid therapy 64 Gleevec resistant 64 hepatorenal syndrome 64 esophageal gastric 64 metastatic uveal melanoma 64 node metastases 64 coagulopathy 64 peritoneal carcinomatosis 64 SIADH 64 Brugada syndrome 64 pancreatic islet cell 64 occlusive disease 64 radiosensitivity 64 metastatic malignant melanoma 64 systemic amyloidosis 64 Hepatocellular Carcinoma HCC 64 endotoxemia 64 neurogenic bladder 64 ductal adenocarcinoma 64 receptor inhibitor 64 immunopathology 64 Eisenmenger syndrome 64 FXIII 64 myotonic muscular dystrophy 64 immune modulator 64 renal allograft 64 Chronic pancreatitis 64 transgenic rats 64 fibrogenesis 64 gefitinib Iressa 64 antiproliferative effects 64 metastatic malignant 64 Ataluren 64 fulminant hepatic failure 64 CYP #D# 64 squamous cell lung cancer 64 hyperalgesia 64 prostate adenocarcinoma 64 basal cell carcinoma BCC 64 extramedullary 63 bacterial prostatitis 63 immunosuppressive therapies 63 cortical dysplasia 63 skeletal metastases 63 neurologic deficits 63 mucinous 63 PTHrP 63 pancreatic endocrine 63 Mitomycin C 63 Intravenous immunoglobulin 63 coagulation abnormalities 63 TPMT 63 Inosine 63 IL 1ß 63 polycythemia vera essential thrombocythemia 63 motor neuron degeneration 63 thrombocytosis 63 multiorgan 63 anti fibrotic 63 radiographic findings 63 lymphoproliferative disease 63 CEACAM1 63 idiopathic pulmonary fibrosis IPF 63 renal scarring 63 gamma secretase inhibitor 63 plasma kallikrein 63 hyperparathyroidism 63 medically refractory 63 monogenic 63 lymphomas leukemias 63 Glypromate 63 Fas ligand 63 Surgical resection 63 upregulating 63 pheochromocytoma 63 cisplatin resistant 63 Leydig cell 63 thrombo embolic 63 cholestasis 63 recurrent glioblastoma 63 steroid refractory 63 MYLOTARG 63 myasthenia gravis MG 63 polyposis 63 chronic thromboembolic pulmonary 63 radiolabeled TM# 63 microvascular dysfunction 63 epithelial barrier 63 gastroduodenal 63 liver metastasis 63 leukaemic stem cells 63 carcinoids 63 Ribavirin causes 63 leukemic stem cells 63 lymphadenopathy 63 rhITF 63 thyroid carcinoma 63 malignant lymphomas 63 tumorigenicity 63 inducible nitric oxide synthase 63 Vascugel ® 63 biochemical abnormalities 63 radioimmunotherapy RIT 63 ischemic mitral regurgitation 63 Teriflunomide 63 discoid lupus 63 neoplastic 63 STRIDE PD 63 mycosis fungoides 63 T1DM 63 flavopiridol 63 lesional 63 papillary carcinoma 63 biliary obstruction 63 transcranial Doppler ultrasound 63 carcinoid tumor 63 mycotic 63 prostate carcinomas 63 anthracycline chemotherapy 63 ximelagatran 63 lymphangiogenesis 63 Epstein Barr virus EBV 63 amyloid deposition 63 extrapulmonary 63 intimal hyperplasia 63 esophagogastric 63 erythema nodosum 63 dyskinetic 63 Natalizumab 63 lymphocytic 63 tricuspid regurgitation 63 functional mitral regurgitation 63 immunosuppressive regimens 63 gastric lymphoma 63 suppurative 63 haematological cancers 63 angiogenesis inhibition 63 denileukin diftitox 63 beta1 integrin 63 leukoencephalopathy 63 MALT lymphoma 63 aortic valve stenosis 63 Lixivaptan 63 cervical lymph nodes 63 arteritis 63 carcinoid 63 node metastasis 63 aerosolized KL4 surfactant 63 relapsed MM 62 EBV infection 62 antithrombotic therapy 62 transabdominal 62 knee osteoarthritis OA 62 intrahepatic 62 TNF antagonist 62 neurological manifestations 62 bicuspid aortic valves 62 nodal metastasis 62 Hurthle cell 62 diagnostic modality 62 nonvascular 62 carcinoid tumors 62 dyskeratosis congenita 62 complement inhibitor eculizumab 62 histone deacetylase inhibitor 62 BCL#A 62 Prognostic factors 62 unruptured aneurysm 62 hepatocellular 62 neoplastic cells 62 transarterial chemoembolization 62 enlarged spleens 62 Interferon beta 62 INS# [001] 62 plasminogen activators 62 intracellular bacteria 62 endocrine tumors 62 NAGS deficiency 62 fibrin deposition 62 SOD2 gene 62 hyperoxaluria 62 Valproic acid 62 polycythemia vera PV 62 uPA 62 diagnostic biomarker 62 Nonspecific 62 DFMO 62 pre malignant lesions 62 Myelodysplastic Syndrome MDS 62 haematological toxicity 62 refractory colorectal cancer 62 LHRH agonists 62 osteolytic 62 Myelodysplastic syndrome 62 C1q 62 TNF α 62 chemoresistant 62 prostate cancer PCa 62 MELAS 62 lung metastasis 62 ischemia reperfusion injury 62 combination antiretroviral therapy 62 Cyclosporin 62 cyclooxygenase 2 62 vascular occlusion 62 bronchial epithelial cells 62 hematopoietic cancers 62 recombinant erythropoietin 62 lichen planus 62 kidney fibrosis 62 IFN beta 62 Hurler syndrome 62 hemolytic 62 stem cell transplantations 62 Immunohistochemical analysis 62 CP CPPS 62 chronic granulomatous disease 62 Sezary syndrome 62 trastuzumab Herceptin ® 62 cytomegalovirus infection 62 idiopathic myelofibrosis 62 pleural effusions 62 N. gonorrhoeae 62 genomic biomarker 62 Lymphoid 62 vasospasm 62 Kinoid 62 HIF 1α 62 torsade de pointes 62 parathyroid 62 kallikrein 62 TRAIL induced apoptosis 62 arterial calcification 62 COL#A# 62 benign neoplasms 62 chronic periodontitis 62 OHR/AVR# 62 thyrotoxicosis 62 acute humoral rejection 62 pituitary adenomas 62 metaplasia 62 Factor XIII 62 Diabetic neuropathy 62 demonstrated antitumor activity 62 recurrent glioblastoma multiforme GBM 62 redox active 62 synthetic retinoid 62 histone acetylation 62 Glioblastoma Multiforme GBM 62 ALI ARDS 62 fibromatosis 62 dexrazoxane 62 trophoblast cells 62 calcineurin inhibitor 62 airway hyperresponsiveness 62 p# biomarker 62 Pseudomonas aeruginosa infections 62 superficial bladder cancer 62 intestinal permeability 62 cystic fibrosis chronic pancreatitis 62 choriocarcinoma 62 intravenous immunoglobulin IVIg 62 thrombocytopenic 62 glomerular 62 anti angiogenic therapy 62 atherosclerotic lesions 62 cardiopulmonary bypass surgery 62 breast carcinoma 62 gastrointestinal stromal tumor 62 neurotrophic 62 papillary renal cell carcinoma 62 ATTR CM 62 cardiac repolarization 62 neoplastic diseases 62 immune modulating 62 ANCA associated 62 mediated inhibition 62 Aortic stenosis 62 isoenzyme 62 epithelial tumors 62 sonographic appearance 62 stratifying patients 62 Chronic Prostatitis 62 platelet dysfunction 62 dopaminergic therapy 62 PAOD 62 BrachySil TM 62 Six3 62 leiomyomas 62 MMP inhibitors 62 Waldenstrom macroglobulinemia 62 ventricular remodeling 62 atherogenesis 62 Certolizumab pegol 62 murine model 62 ABL1 62 Alequel 62 metastatic colorectal 62 cervical carcinoma 62 mineralocorticoid 62 underlying pathophysiology 62 hemodilution 62 microsphere therapy 62 lymphocyte activation 62 Fenretinide 62 parasitemia 62 intravascular hemolysis 62 genitourinary cancers 62 nattokinase 62 Hypotension 62 chronic myeloid 62 Akt activation 62 EGFR HER2 62 ganciclovir 62 paricalcitol 62 pathogenetic 62 receptor tyrosine kinase inhibitor 62 hypercalcaemia 62 allogeneic bone marrow 62 Autoimmune hepatitis 62 myelodysplasia 62 recurrent glioma 62 physiologic mechanisms 62 keloid scars 61 myelomas 61 intestinal polyps 61 acetonide FA 61 lactate dehydrogenase LDH 61 Adjuvant chemotherapy 61 Surgical excision 61 liposomal amphotericin B 61 IgG4 61 lenalidomide dexamethasone 61 autologous transplantation 61 Deep venous thrombosis 61 clevidipine 61 tissue oxygenation 61 pharmacokinetic interactions 61 FTIs 61 adrenalectomy 61 enterococcal 61 neuritic 61 CTAP# Capsules 61 hemorrhagic cystitis 61 hypoxic tumors 61 gastric carcinoma 61 antiplatelet therapies 61 pretransplant 61 plasma pharmacokinetics 61 Factor VIIa 61 myopathies 61 Epstein Barr Virus EBV 61 chemoradiotherapy 61 nasopharyngeal carcinoma 61 deferiprone 61 limbal stem cell 61 hypocalcaemia 61 diabetic gastroparesis 61 anterior uveitis 61 bronchial inflammation 61 metastatic lymph nodes 61 Islet transplantation 61 infective endocarditis 61 SYN# 61 Glioblastoma Multiforme 61 antiangiogenesis 61 allogeneic hematopoietic stem cell 61 myocardial function 61 CTEPH 61 VAPRISOL 61 MGUS 61 Glucocorticoid 61 osteogenic 61 paraganglioma 61 Chronic lymphocytic leukemia 61 bleomycin 61 sCD# 61 FDG PET imaging 61 mutated K ras 61 gallium nitrate 61 proteoglycan 61 lumbar spinal stenosis LSS 61 atypical hemolytic uremic syndrome 61 paraneoplastic 61 immunodeficiency disorders 61 multimodality therapy 61 prostate cancer CaP 61 hepatic fibrosis 61 BoNTA 61 type 1diabetes 61 cystic lesions 61 mycophenolate mofetil MMF 61 refractory prostate cancer 61 autosomal dominant polycystic kidney 61 colorectal carcinoma 61 vinca alkaloid 61 thalidomide Thalomid 61 metastatic adenocarcinoma 61 recurrent ovarian 61 mitochondrial toxicity 61 humanised monoclonal antibody 61 apoptotic pathway 61 Prostatitis 61 pancreatic adenocarcinoma 61 Inhaled nitric oxide 61 myeloablative 61 miglustat 61 LPS induced 61 synovial cells 61 thrombolytic agents 61 alkylating agent 61 imatinib therapy 61 epithelial ovarian 61 rituximab Rituxan 61 levodopa induced 61 FVIII inhibitors 61 chronic GVHD 61 neovascular 61 peripheral arterial 61 ERK signaling 61 lupus anticoagulant 61 erythropoiesis 61 myeloproliferative diseases 61 pulmonary toxicity 61 nonhuman primate model 61 neuroblastoma tumors 61 thymoma 61 demyelinating 61 vaso occlusive crisis 61 cholangiocarcinoma 61 dermatologic reactions 61 idiopathic PAH 61 Parathyroid hormone 61 HbF 61 neovascular diseases 61 Anthracycline 61 SERCA2a 61 pharmacologic intervention 61 cardiac hypertrophy 61 colorectal neoplasms 61 SIR Spheres 61 fallopian tube carcinoma 61 angiographically 61 oral anticoagulant therapy 61 squamous cell carcinoma SCC 61 selective inhibition 61 fosbretabulin 61 neuroendocrine carcinoma 61 insertional 61 neurogenic 61 Aviptadil 61 interleukin IL -# 61 EXJADE 61 diagnose coronary artery 61 verteporfin 61 Dacogen decitabine 61 Aggrastat ® tirofiban hydrochloride 61 vasculopathy 61 transfusion syndrome 61 MPGN 61 nimodipine 61 immunomodulation 61 transplantation HCT 61 neoplastic lesions 61 nonischemic 61 von Willebrand 61 Duchenne muscular dystrophy DMD 61 antiplatelet medications 61 follicular thyroid cancer 61 upregulates 61 NF kappaB activation 61 chemo immunotherapy 61 ischemia reperfusion 61 constipation predominant irritable bowel 61 intracerebral 61 cediranib 61 hypoperfusion 61 hyperammonemia 61 chemosensitivity 61 hypervascular tumors 61 H pylori 61 chemoresistance 61 idraparinux 61 neurocognitive deficits 61 Acute myeloid leukemia 61 oncomodulin 61 basiliximab 61 E selectin 61 antitumor efficacy 61 IGFBP2 61 relapsed ovarian cancer 61 biliary stones 61 purpura 61 atherothrombotic 61 malignant prostate 61 prostate epithelial cells 61 Papillary 61 β blockers 61 thiopurine 61 von Willebrand Disease 61 acute myocardial ischemia 61 FGFR3 61 delayed CINV 61 malignant pleural mesothelioma 61 filaggrin 61 5alpha reductase 61 systemic fungal infections 61 Magnesium deficiency 61 eculizumab therapy 61 ara C 61 adrenocortical 61 selective modulator 61 hyperacute 61 undergoing peritoneal dialysis 61 heparin induced thrombocytopenia 61 radioiodine therapy 61 differential gene expression 61 HepG2 cells 61 intraventricular 61 Sjögren syndrome 61 dilated cardiomyopathy DCM 61 Metastatic breast cancer 61 systemic hypotension 61 beta globin gene 61 mutated KRAS gene 61 intravenous cyclophosphamide 61 glomerular filtration 61 hyperplastic 61 secondary hyperparathyroidism 61 pancreatic carcinoma 61 transgene expression 61 syncope fainting 61 histopathological examination 61 P selectin 61 superior mesenteric artery 61 uricase 61 thyroglobulin 61 hyperprolactinemia 61 bone morphogenic protein 61 ERK1 2 61 cerebral ischemia 61 cartilage degeneration 61 invasive candidiasis 61 NSF NFD 61 ABCB1 61 portal vein thrombosis 61 NMIBC 61 remyelination 61 lymphatic vasculature 61 recurrent laryngeal nerve 61 thymosin beta 4 61 hepatitis C viral infection 61 PROCHYMAL 61 chronic idiopathic thrombocytopenic purpura 61 multicentric 61 Leukemias 61 sorafenib Nexavar 61 metastatic RCC 61 sarcomatoid 61 fulvestrant 61 Estradiol 61 anti angiogenic agents 61 retransplantation 61 perineural 61 Heavy menstrual bleeding 61 hepatic liver 61 Temsirolimus 61 CD4 + T lymphocytes 61 immunoregulation 61 bovine thrombin 61 mutated KRAS 61 clinically detectable 61 Hypertrophy 61 AA amyloidosis 61 MYCN amplification 61 mucociliary clearance 61 adjuvant radiotherapy 61 autoimmune pancreatitis 61 busulfan 61 cartilage defects 61 sclerosing 61 tumor necrosis 61 antiangiogenic agent 61 neuroinflammatory 61 Bosentan 61 grade cervical intraepithelial 61 hematologic disorders 61 myocardial reperfusion 61 efalizumab 60 NOD mouse 60 microsatellite instability 60 juvenile idiopathic arthritis 60 biomarker identification 60 myeloproliferative 60 thyroid nodules 60 small molecule activators 60 Clusterin 60 E. faecalis 60 osteoblastic 60 hyperphenylalaninemia HPA due 60 Cardiotoxicity 60 fallopian tube cancers 60 renovascular hypertension 60 postoperative morbidity 60 transarterial 60 pleural fluid 60 Plasmin 60 idarubicin 60 JAK STAT signaling 60 relapsing remitting MS RRMS 60 vidofludimus 60 JAK3 60 effector function 60 visilizumab 60 oral prodrug 60 Lisofylline 60 cranial irradiation 60 ocular disorders 60 haemo 60 MGd 60 liver resection 60 pelvic malignancies 60 vascularisation 60 cytoreductive surgery 60 post surgical adhesions 60 anticholinergic agents 60 fibrosarcoma 60 BRCA deficient 60 innate immune responses 60 dual endothelin receptor antagonist 60 thromboembolic complications 60 cinacalcet 60 percutaneous drainage 60 hepatic metastases 60 molecular abnormalities 60 peritoneal cancer 60 prostanoid 60 extracranial 60 Vidaza azacitidine 60 vascular thrombosis 60 CMV infection 60 Pharmacokinetic studies 60 acute hepatic 60 Hydroxyurea 60 allogeneic transplants 60 Helicobacter 60 demethylation 60 variceal 60 NOD mice 60 IFN β 60 Thyroid disorders 60 pancreatic tissue 60 1 diabetes T1D 60 CBLC# 60 veno occlusive disease 60 alagebrium 60 pseudoaneurysm 60 pelvic lymphadenectomy 60 thymic carcinoma 60 bronchogenic carcinoma 60 alveolar epithelial cells 60 H. pylori eradication 60 neuronal degeneration 60 Arranon 60 tissue perfusion 60 paragangliomas 60 noscapine 60 Myotonic dystrophy 60 vasodilatation 60 pancreatic transplantation 60 lymphocytic leukemia 60 proliferative disorders 60 fibroma 60 TTR amyloidosis 60 hypercalcemia 60 nephrotoxicity 60 aminotransferase 60 TGF ß 60 percutaneous biopsy 60 leukocyte adhesion 60 osteoblast 60 polyomavirus nephropathy 60 sinonasal 60 immune thrombocytopenic purpura 60 acute myocarditis 60 histologic findings 60 LRAT 60 Dasatinib 60 lymphoid cells 60 KRAS oncogene 60 lymphoproliferative disorder 60 liver decompensation 60 methicillin susceptible Staphylococcus aureus 60 perfusion MRI 60 osteosarcomas 60 multidrug resistance 60 Pemphigus 60 diabetes mellitus DM 60 glomerulonephritis 60 Liver transplantation 60 mTOR mammalian target 60 refractory Hodgkin 60 FVIIa 60 HIF 1a 60 immunomodulatory therapy 60 GH deficiency 60 Lyme arthritis 60 IL 1β 60 mediastinitis 60 TGF beta signaling 60 diabetic polyneuropathy 60 PHPT 60 aromatase inhibitor therapy 60 clinicopathological 60 FUSILEV enhances 60 JAK2 enzyme 60 cardiolipin 60 Vidofludimus 60 autologous bone marrow 60 superficial femoral 60 cellular prion protein 60 Enzyme Replacement Therapy 60 interstitial pneumonia 60 palifermin 60 Nilotinib 60 malignant pancreatic 60 orchitis 60 neuropsychiatric diseases 60 recurrent metastatic 60 dissolving clots 60 anemias 60 vestibular schwannomas 60 nicardipine 60 myeloperoxidase 60 acute leukemias 60 fibrinolytic 60 Peyronie 60 pouchitis 60 tumoral 60 bulbar 60 Cardiopulmonary bypass 60 Tacrolimus 60 histologically proven 60 acadesine 60 Gorlin syndrome 60 mycophenolate mofetil 60 adrenocortical cancer 60 NPM1 mutation 60 neointimal hyperplasia 60 herpetic 60 RRM1 60 Myasthenia gravis 60 chromosomal rearrangement 60 urologic diseases 60 peripheral artery 60 vWF 60 protein tyrosine phosphatase 1B 60 balloon dilatation 60 endothelial activation 60 corneal edema 60 eosinophilic 60 Adult Stem Cell Therapy 60 pyelonephritis 60 corticosteroid induced 60 HCV replication 60 pericardial effusion 60 ADVEXIN therapy 60 invasive carcinoma 60 hepatic encephalopathy HE 60 immuno modulatory 60 BRAF V#E mutation 60 PC# cells 60 AT1R 60 c myc gene 60 cirrhosis liver failure 60 intravesical therapy 60 varices 60 hematopoietic malignancies 60 interstitial fibrosis 60 Haptoglobin 60 splenic 60 lymphatic vessel 60 thyroid deficiency 60 endocrine therapies 60 Angiotensin II 60 alveolar rhabdomyosarcoma 60 rheumatic disorders 60 CYP #A# 60 hypereosinophilic syndrome 60 Fanconi syndrome 60 pulmonary artery banding 60 B Cell Lymphoma 60 pretreatment serum 60 endostatin 60 replicase 60 PIK3CA 60 somatostatin analog 60 methotrexate therapy 60 pancreatic ductal 60 mGluR2 NAM 60 femoral neck fracture 60 FVIII 60 potent inducer 60 autoimmune thyroiditis 60 abacavir Ziagen 60 Polycythemia vera 60 CTGF 60 GRNCM1 60 pyrimethamine 60 Diabetic Neuropathy 60 antifungal therapy 60 pathophysiological mechanisms 60 thymidylate synthase TS 60 immunosuppressive regimen 60 neuroendocrine tumors 60 p# MAPK 60 smoldering multiple myeloma 60 hepatotoxicity 60 nephrosis 60 Diabetic Foot Ulcer 60 IGFBP 3 60 symptomatic intracranial 60 Prostate Px + 60 p#NTR 60 pelvic irradiation 60 dissolving blood clots 60 ocular infections 60 mitomycin C 60 preoperative chemotherapy 60 histologic subtype 60 Acute Renal Failure 60 cardioprotection 60 hepatic cirrhosis 60 thromboembolic 60 pain palliation 60 Lymphocytic 60 antibody mediated rejection 60 annexin V 60 intravenous bisphosphonates 60 recurrent malignant glioma 60 tamoxifen Nolvadex ® 60 platelet inhibitor 60 decompensated heart failure 60 mTOR inhibition 60 cerebral angiography 60 Estrogen Receptor 60 nonmelanoma skin cancers 60 HepDirect prodrug 60 GISTs 60 postoperative AF 60 gonococcal 60 renal kidney 60 Achilles tendon ruptures 60 mGluR5 inhibition 60 transaminase elevations 60 venous thromboembolic disease 60 antiangiogenic 60 pulmonary infiltrates 60 mesenteric 60 patients undergoing CABG 60 EGFR receptor 60 oral anticoagulation 60 CGRP 60 carcinoembryonic antigen 60 preclinically 60 Squamous 60 cilengitide 60 urolithiasis 60 erlotinib Tarceva 60 malignant ovarian 60 phenelzine 60 DAPT 60 GW# [003] 60 postoperative pulmonary 60 intrathoracic 60 ON #.Na 60 terlipressin 60 myocardial ischaemia 60 autoimmune encephalitis 60 idiopathic thrombocytopenic purpura 60 Spinal cord 60 endometrioid 60 ZACTIMA 60 immune globulins 60 corneal neovascularization 60 vasoactive 60 allergic airway 60 hilar 60 LVNC 60 variceal bleeding 60 cutaneous squamous cell carcinoma 60 endometrial hyperplasia 60 NQO1 60 PPARγ 60 colorectal cancer liver metastases 60 leukemias lymphomas 60 acinar 60 tryptase 60 Hashimoto thyroiditis 60 Lupus nephritis 60 graft dysfunction 60 nonmetastatic 60 corneal graft 60 proliferative retinopathy 60 jejunal 60 pentamidine 60 axonal regeneration 60 smoldering myeloma 60 sacral nerve stimulation 60 embryonal rhabdomyosarcoma 60 choroidal neovascularization CNV 60 autoregulation 60 ischemic vascular 60 AST ALT 60 idiopathic thrombocytopenic purpura ITP 60 included exfoliative dermatitis 60 ectopic expression 60 LHON 60 HuR 60 edifoligide 60 gastrointestinal motility